Digital & Innovation

J&J and Apple launch new mHealth study to reduce the risk of stroke

Health Industry Hub | March 2, 2020 |
[Total: 1    Average: 4/5]

Digital & Innovation: Apple is partnering with Johnson & Johnson (J&J) on a new mHealth study to determine whether the Apple Watch and an accompanying app can help reduce the risk of stroke.

The study is designed to explore if the Heartline Study app on iPhone and heart health features on Apple Watch can improve health outcomes, including reducing the risk of stroke, with earlier detection of atrial fibrillation (AFib). 

AFib is a type of irregular heart rhythm that occurs when the heart’s upper and lower chambers do not beat in sync. As a result, blood clots can develop in the heart and travel to the brain, making AFib one of the most common causes of stroke. There are many unknowns around AFib, and because there are often no symptoms, many people who have it remain undiagnosed.

If doctors are able to identify and treat AFib earlier, they may be able to reduce the risk of these fatal and disabling strokes, says cardiologist C. Michael Gibson, M.D., CEO of the Baim Institute for Clinical Research and founder of the Perfuse Study Group at Harvard Medical School. That’s why Gibson—who’s studied cardiovascular health for 38 years—is consulting with Johnson & Johnson and co-leading the multiyear virtual Heartline Study.

Suppliers & Service Providers: Enhance business visibility, differentiate your brand and maximise your reach. Discover our unique digital media solutions with superior open rates and click through rates.

This study follows on the heels of the Apple Heart Study, to date the largest analysis of mHealth data from a wearable device. Launched in 2017 by the Stanford University School of Medicine, Apple and American Well, the study attracted almost 420,000 participants and laid the groundwork for the viability of ECG sensors for detecting AFib.

Participants in the study will use an Apple Watch and Heartline Study app, which alerts the user when the smartwatch detects an irregular heart rhythm and advises him or her to seek advice from a healthcare provider. The app, which also provides information and resources to the user, can be triggered to personalize that information if a care provider confirms an AFib diagnosis or if the user isn’t engaged with the program.

“The decision to take action is the responsibility of the participant, but the Heartline Study app will provide additional prompting and educational materials to help people make informed decisions,” Gibson said.

Register FREE to receive the latest industry news, innovations and insights from Health Industry Hub; the ONLY one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.


About the author

About the author

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam luctus finibus scelerisque. Nunc bibendum ipsum sed augue fringilla fringilla. Nullam at consectetur leo. Praesent viverra rutrum porta. Quisque vitae mi vel purus vulputate tincidunt. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Suspendisse et mi quis nisi rhoncus feugiat at ac tellus. Sed aliquam sodales nulla ac auctor. Sed pretium lobortis purus accumsan ullamcorper. Phasellus sodales vel odio in lobortis. Duis maximus sagittis bibendum. Interdum et malesuada fames ac ante ipsum primis in faucibus. Nunc dictum tincidunt ipsum in vestibulum. Donec ut sem consectetur, aliquam quam vitae, pharetra orci. Nam egestas non velit eu rhoncus. Duis congue neque non lacus tincidunt porta. Vestibulum ultricies pulvinar sem, molestie congue dui aliquet non.
  • Ut imperdiet leo id lorem fermentum consectetur.
  • Ut vitae orci et dui varius tincidunt.
  • Ut id magna non libero vestibulum pharetra ac faucibus nulla.
Aliquam erat volutpat. Vestibulum vitae varius diam. Nulla eget congue ante. Nunc ullamcorper sagittis augue vel dictum. Mauris finibus nibh ut pulvinar auctor. Vestibulum ut faucibus nisi. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque porta tortor ac justo malesuada elementum. Nulla tellus ante, cursus nec ex sit amet, suscipit bibendum arcu. Duis posuere orci dui, et mollis enim dictum at. Sed ullamcorper, sapien ut vulputate viverra, sem purus porttitor tellus, nec mattis mauris ligula sed risus. Nulla sagittis id ipsum eu mattis. Link to full profile

News & Trends - Medical Technology

MedTech news - New 5 minute coronavirus test delivers clear results on infection

New 5 minute coronavirus test delivers clear results on infection

Health Industry Hub | April 9, 2020 |

A new type of sensor device from the German health technology company Digital Diagnostics AG can be used for immediate […]

More


Marketing & Strategy

Marketing & Strategy in Healthcare - Customer-Centric Engagement During COVID-19

Customer-Centric Engagement During COVID-19

Health Industry Hub | April 8, 2020 |

Navigating the multichannel maze in COVID 19 times to engage healthcare professionals (HCPs) and patients has been challenging for most […]

More


News & Trends - Medical Technology

MedTech News - Stryker launches limited-release medical bed to support critical needs during COVID-19 pandemic

Stryker launches limited-release medical bed to support critical needs during COVID-19 pandemic

Health Industry Hub | April 8, 2020 |

MedTech News: Stryker has developed a low-cost, limited-release emergency response bed to quickly aid healthcare providers with efficient care during […]

More


Medical

Medical News - AMA urges Australians to continue with ongoing medical care amid COVID-19 crisis

AMA urges Australians to continue with ongoing medical care amid COVID-19 crisis

Health Industry Hub | April 8, 2020 |

Medical News: The AMA is urging people to keep a close watch on their ongoing health care and maintenance, and […]

More